 NEW YORK, Sept. 21, 2022 GLOBE NEWSWIRE -- Axsome Therapeutics, Inc. NASDAQ: AXSM, a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system CNS disorders, today announced that Herriot Tabuteau, MD, Axsomes Chief Executive Officer, will participate in a fireside chat at the Ladenburg Thalmann Healthcare Conference on Thursday, September 29, 2022 at 9:30 AM Eastern Time. The conference will be held at the Sofitel New York in New York City. 